Cite
HARVARD Citation
Li, C. et al. (2021). Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial. Annals of medicine. pp. 391-401. [Online].